Pfizer Chairman & CEO Albert Bourla Acquires Phantom Stock via Savings Plan
PFIZER INC
Subscribe to track PFE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 4 Filed for Pfizer Inc ($PFE) Insider: Albert Bourla (Chairman & CEO) Transaction: Acquired 71.00 Phantom Stock Units at $28.37 ($2,014.27 total value) Date: 2026-10-13 Post-Transaction Holdings: 783,981 units Significance: Low (Routine deferred compensation / supplemental savings plan acquisition)
Comprehensive Analysis
Executive Summary
On October 14, 2026, Pfizer Inc. ($PFE) filed a Form 4 on behalf of Chairman and CEO Albert Bourla. The filing reports the acquisition of 71 phantom stock units on October 13, 2026, at a price of $28.37 per share, totaling approximately $2,014.27.
Transaction Breakdown
- Security: Phantom Stock Units SSP
- Transaction Code: 'A' (Award/Grant/Acquisition under an employee benefit plan)
- Shares Acquired: 71.0000
- Price per Unit: $28.37
- Gross Value: $2,014.27
- Post-Transaction Beneficial Ownership: 783,981 phantom stock units
Context and Footnote Details
According to the footnotes, these phantom stock units were acquired under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan. Each unit represents one phantom share of common stock and is payable in cash following separation from service, or transferable into alternative investment accounts.
Market & Trading Significance
This transaction carries Low trading significance as it represents routine supplemental savings and deferred compensation participation rather than an open-market discretionary purchase or sale.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.